student
School of Medicine, Anhui University of Science and Technology, Huainan, China
Tong Hanxing, male, 44 years old, holds a Ph.D. in Surgery from Fudan University, Deputy Chief Physician of General Surgery, National Committee Member of the Retroperitoneal and Pelvic Floor Diseases Professional Committee of the Chinese Association of Research Hospitals, and Deputy Chairman of the Youth Committee of the Soft Tissue Oncology Professional Committee of the Chinese Association for the Promotion of Medicine. Mainly engaged in molecular mechanism research and metabolic related research on the occurrence and development of retroperitoneal sarcoma. Participated in multiple national level projects, including the National Natural Science Foundation Committee and the Youth Science Foundation Project, 81702307, to study the mechanism of differential expression of IncRNA in imatinib resistant gastrointestinal stromal tumor cells; Led the Shanghai Municipal Commission of Science and Technology Nano Special Fund project, 12nm0501402, on the impact of miRNA targeted regulation of IGF1R on the biological behavior of GIST cells; Youth Fund of Fudan University, FB201101, Screening of stem cell specific miRNAs for pancreatic cancer; Participated in the compilation and translation of four monographs; Participated in patent publication on the use of FXR agonists in the preparation of drugs for the treatment of liposarcoma related diseases; Published 10 papers as first author or co first author in SCI journals, with a cumulative impact factor of 47.5 points. In recent years, in-depth exploration has been conducted on the basic research and clinical retrospective analysis of retroperitoneal sarcoma.
